How Is Functional Food Advertising Understood? An Approximation in University Students

In functional food advertising, messages are not always easily understandable for the target audience. Current European legislation, enforced through Regulation 1924/2006, specifies that such messages should be clear and precise so as not to mislead the consumer. The objective of this study was to observe consumers’ understanding of messages in functional food advertisements. The methodology used was a self-administered survey filled out by 191 students enrolled in a Degree in Advertising and Public Relations at the University of Alicante (Spain). The results suggest that a large number of students do not know what functional food is and obtain information about these products mainly from labelling/packaging. The major means of communication through which they learn about health benefits via advertising is the internet, followed by television. Most respondents indicated that they understood related advertisements and found it helpful to be given additional information on health benefits. Worthy of note, the greater their level of understanding of the messages, the higher their level of distrust of advertising messages, which they considered to be deceptive or misleading.This research was conducted under the R&D&i project “Reclamos de salud en la publicidad de alimentos y comprensión del consumidor” (“Health claims in food advertising and consumer understanding”-GV/2016/088), funded by the Generalitat Valenciana, Spain and directed by Cristina González Díaz

Reporte de un brote de infección por SARS-CoV-2 por transmisión aérea: evidencia epidemiológica y molecular

Introduction: It has been shown that the transmission of SARS-CoV-2 occurs mainly by air, and the risk of infection is greater in closed spaces. Objective: Describe the epidemiology, virology and molecular characterization of a COVID-19 outbreak at a closed vaccination point during the third wave of SARS-CoV-2 in Colombia. Materials and methods: Diagnostic tests, interviews, sampling, cell cultures and viral sequencing were carried out, the latter being molecular characterization and lineage identification. Results: Seven workers were positive for SARS-CoV-2; among these, 3 samples were analyzed, plus an additional sample belonging to the mother of the presumed index case; all samples were identified with lineage B.1.625, with a maximum of 2 nucleotides difference between them. Conclusions: Variant B.1.625 was identified as the cause of the COVID-19 outbreak, and a co-worker was also identified as the index case. Unexpectedly, attending a vaccination day became a risk factor for acquiring the infection.Introducción. Se ha demostrado que la transmisión de SARS-CoV-2 se da principalmente por vía aérea y el riesgo de infección es mayor en espacios cerrados con alta concentración de personas; este último factor se presentó en algunos de los puestos de vacunación de la ciudad de Medellín. Objetivo. Describir la epidemiología, virología y caracterización molecular de un brote de COVID-19 en un punto de vacunación cerrado durante la tercera ola de SARS-CoV-2 en Colombia. Materiales y métodos. Se realizaron test diagnósticos, entrevistas, toma de muestras, aislamiento viral y secuenciación genómica. Con esta última se realizó caracterización molecular e identificación de linaje. Resultados. Siete trabajadores fueron positivos para SARS-CoV-2, y de estos, tres muestras fueron secuenciadas, más una muestra adicional perteneciente a la madre del presunto caso índice. Todas las muestras fueron identificadas con el linaje B.1.625, con un máximo de 2 nucleótidos de diferencia entre ellas. Conclusiones. Se identificó la variante B.1.625 como la causante del brote de COVID-19, y también un compañero de trabajo fue identificado como el caso índice. De forma imprevista, asistir a una jornada de vacunación se convirtió en un factor de riesgo para adquirir la infección

Utilización de agar Mueller Hinton en micología. Parte I

Con el fin de probar la utilidad del Agar Mueller Hinton en micología médica, para futuros ensayos con drogas antifúngicas, se compara el desarrollo de Dermatofitos (M. canis, M. gypseum, T. rubrum, T. mentagrophytes y E. floccosum) y especies de Candida en este medio y en ASG 20% - 40%, YMA y DST. Se comprueba que el Agar Mueller Hinton es tan eficaz como el ASG para el crecimiento de estos hongos en los plazos recomendados para estudios de sensibilidad

Phylogenetic, Cytogenetic and Morphological Evidences are Critical for Recognizing a New Genus: Valdesiana, an Iberian Intergeneric Allopolyploid Between Schenkia and Exaculum

The present taxonomic status of Schenkia elegans, endemism recently described in the Iberian Peninsula, and its relationship with the sympatric and the nearest morphological species Schenkia spicata and Exaculum pusillum is revaluated. Different kinds of evidence based on plant morphology, ploidy estimation by flow cytometry, karyotype characterisation, and phylogenetic data have been analysed. Two maternally inherited plastid DNA regions (trnL intron and trnL-F spacer) and biparentally inherited nuclear ribosomal DNA sequence region (nrDNA ITS) have been used. Comparative multivariate analyses show an intermediate morphology of the S. elegans plants between the other two species studied. Flow cytometry and karyotype analyses in S. elegans point to an allopolyploid origin, with the latter constituted by a mixture of those of the diploids S. spicata and E. pusillum. Phylogenetic analyses based on plastid and nuclear DNA regions cluster S. elegans in two different clades, those of S. spicata and E. pusillum, suggesting a possible hybrid origin of S. elegans between both species, acting as maternal or paternal progenitors. In consequence, taking in consideration the taxonomic relationships among genera (Exaculum, Schenkia and the closely related genus Zeltnera found in America), a monotypic genus Valdesiana gen. nov. is proposed to accommodate the allopolyploid species, combined as V. elegans, for which immediate conservation measures must be evaluated.Ministerio de Economía y Competitividad CGL2013-45037-Pproject CULTIVAR CENTRO-01-0145-FEDER-00002

Analysis of microbial populations in Rusitec fermenters fed diets of variable composition

Trabajo presentado al : Joint Annual Meeting. ADSA-ASAS. Orlando Florida (USA), julio, 2015. T485Fermenters are widely used to study ruminal fermentation, but infonnation on microbial populations developing in fermenters over the incubation period is limited. Four Rusitec fermenters were fed 2 diets representative of those administered to dairy sheep (DAI; 50:50 alfalfa hay:concentrate) and fattening lambs (FAT; 15:85 barley straw:concentrate) in a crossover design with 2 14-d incubation periods to assess the evolution of the microbial populations. There were 4 fermenters per diet. The fermenters received daily 30 g of diet DM and samples from liquid (LIQ) and solid (SOL) digesta were taken on d 3, 8 and 14, and stored frozen at-80ªC until DNA extraction. Concentrations ofbacterial and protozoal DNA and relative abundance offungi and methanogenic archaea to total bacteria! DNA concentration were detennined by real time PCR using previously validated primers and DNA from bacteria and protozoa isolated from sheep rumen as standards. Data were analyzed as a mixed model with repeated measnres using the PROC MlXED of SAS. The model included diet, incubation nm, time, and diet x tin1e as fixed effects, and fermenter as a random effect. Diet x sampling time interactions (P > 0.05) were detected for bacteria! and protozoal DNA concentrations in both digesta phases. The bacteria! DNA concentrations in SOL did not change (P = 0.002) over the incubation period, whereas concentrations in LIQ increased (P < 0.001) by 1.5 and 1.8 times for DAI and FAT diets by the end ofthe incubation, respectively. Protozoal DNA concentrations on d 14 were 37.8 and 8.0 times lower (P < 0.001; means across diets) than those on d 3 for SOL and LIQ phases, respectively. Relative abundance offungi decreased (P < 0.05) with time in both phases, and that ofmethanogenic archaea remain unchanged in LIQ and increased (P = 0.021) in SOL. Concentration of bacteria! and protozoal DNA and the relative abundance of methanogenic archaea were greater in the fermenters fed the DAI diet (P < 0.05) compared with FAT diet. The results show that microbial populations in Rusitec fermenters are affected by the incubated diet and change over the incubation periodPeer reviewe

NOTAS MICOLOGICAS VI. Pleurophomopsis lignicola Y Cladophialophora bantiana DOS NUEVOS AGENTES DE MICOSIS OPORTUNISTAS EN CHILE

Se comentan los aspectos ecológicos, morfológicos y taxonómicos de 2 interesantes agentes etiológicos de micosis oportunistas no descritos en el país. El primero, un paciente de sexo masculino de 50 años, con lupuseritematoso diseminado y multiples infecciones bacterianas, donde desde un absceso cutáneo del dedo indice se aisló repetidamente Pleurophomopsis lignicola. El segundo, un paciente de sexo masculino 68 años, agricultor conabscesos cerebrales múltiples donde se aisló el agente fúngico neurotrópico Cladophialophora bantiana

NOTAS MICOLOGICAS VI. Pleurophomopsis lignicola Y Cladophialophora bantiana DOS NUEVOS AGENTES DE MICOSIS OPORTUNISTAS EN CHILE

Se comentan los aspectos ecológicos, morfológicos y taxonómicos de 2 interesantes agentes etiológicos de micosis oportunistas no descritos en el país. El primero, un paciente de sexo masculino de 50 años, con lupuseritematoso diseminado y multiples infecciones bacterianas, donde desde un absceso cutáneo del dedo indice se aisló repetidamente Pleurophomopsis lignicola. El segundo, un paciente de sexo masculino 68 años, agricultor conabscesos cerebrales múltiples donde se aisló el agente fúngico neurotrópico Cladophialophora bantiana

Effect of acute and chronic red wine consumption on lipopolysaccharide concentrations

Background: Chronic red wine (RW) consumption has been associated with decreased cardiovascular disease risk, mainly attributed to an improvement in lipid profile. RW intake is also able to change the composition of gut microbiota. High fat intake has recently been reported to increase metabolic endotoxemia. The gut microbiota has been proposed as the main resource of plasma lipopolysaccharides (LPSs) in metabolic endotoxemia. Objective: We analyzed the effect on LPS concentrations of chronic RW consumption and acute RW intake in relation to high fat intake in middle-aged men. Design: For the chronic study, 10 middle-aged male volunteers were randomly assigned in a crossover trial, and after a washout period, all subjects received RW, dealcoholized red wine (DRW), or gin for 20 d. Serum endotoxin and LPS-binding protein (LBP) concentrations were determined after the washout period and after each of the treatments, and changes in fecal microbiota were quantified. For the acute study, 5 adult men underwent a fat overload or a fat overload together with the consumption of RW, DRW, or gin. Baseline and postprandial serum LPS and LBP concentrations and postprandial chylomicron LPS concentrations were measured. Results: There were no significant differences in the change in LPS or LBP concentrations between chronic RW, DRW, and gin consumption. Bifidobacterium and Prevotella amounts were significantly increased by RW and correlated negatively with LPS concentrations. There were no differences in postprandial serum LPS, LBP, or chylomicron LPS concentrations between acute RW, DRW, or gin intake together with a fatty meal. Conclusion: Chronic RW consumption increases Bifidobacterium and Prevotella amounts, which may have beneficial effects by leading to lower LPS concentrations. This trial was registered at controlled-trials.CIBER, CB06/03/0018 of the Instituto de Salud Carlos III (ISCIII), the ISCIII FIS PS09/00997, “Consejeria de Innovación (Junta de Andalucia)” CTS04369, “Consejeria de Salud” (Junta de Andalucia) PI696/2010; in part by the INGENIO-CONSOLIDER Program, Fun-C-Food CSD2007-063 and AGL2006-14228-C03-02 from the Spanish Ministry; and by Programa de Formación de Profesorado Universitario (FPU) grants from Education Ministry, Madrid, Spain [AP2009-4537 (to MC-P) and AP2008-01922 (MB-O)]. Torres SA provided the red wine and dealcoholized red wine used in the study, and Gin Xoriguer provided the gin used in the study

The Experience With Health Care of Patients With Inflammatory Arthritis: A Cross-sectional Survey Using the Instrument to Evaluate the Experience of Patients With Chronic Diseases

[Abstract] Background: Patients' experience with health care is becoming a key component for the provision of a patient-centered health care model. The aim of this study was to assess the experience with health care of patients with inflammatory arthritis and patient- and health care-related factors. Methods: Patients responded to an anonymous survey provided by their treating clinical teams. The survey comprised the validated 12-item IEXPAC (Instrument to Evaluate the EXperience of PAtients with Chronic diseases) tool and demographic variables and health care-related characteristics that may affect patients' experience. Results: A total of 359 of 625 surveys were returned (response rate, 57.4%). Overall, patient responses were positive (>60% gave "always/mostly" answers) for statements assessing the interaction between patients and health care professionals or patient self-management following health care professional guidance. However, positive patient responses for items regarding patient interaction with the health care system via the internet or with other patients were less than 13%. Only 25.6% of patients who had been hospitalized reported receiving a follow-up call or visit following discharge. In the bivariate analysis, experience scores were higher (better experience) in men, those seen by fewer specialists or by the same physician, and in patients treated with a fewer number of drugs or with subcutaneous/intravenous drugs. Multivariate analyses identified regular follow-up by the same physician and treatment with subcutaneous/intravenous drugs as variables associated with a better patient experience. Conclusions: This study identifies areas of care for patients with inflammatory arthritis with the potential to improve patients' experience and highlights the importance of patient-physician relationships and comprehensive patient care

Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis

[Abstract] Background: In the present study, we explored potential protein biomarkers useful to predict the therapeutic response of knee osteoarthritis (KOA) patients treated with pharmaceutical grade Chondroitin sulfate/Glucosamine hydrochloride (CS+GH; Droglican, Bioiberica), in order to optimize therapeutic outcomes. Methods: A shotgun proteomic analysis by iTRAQ labelling and liquid chromatography–mass spectrometry (LC-MS/MS) was performed using sera from 40 patients enrolled in the Multicentre Osteoarthritis interVEntion trial with Sysadoa (MOVES). The panel of proteins potentially useful to predict KOA patient’s response was clinically validated in the whole MOVES cohort at baseline (n = 506) using commercially available enzyme-linked immunosorbent assays kits. Logistic regression models and receiver-operating-characteristics (ROC) curves were used to analyze the contribution of these proteins to our prediction models of symptomatic drug response in KOA. Results: In the discovery phase of the study, a panel of six putative predictive biomarkers of response to CS+GH (APOA2, APOA4, APOH, ITIH1, C4BPa and ORM2) were identified by shotgun proteomics. Data are available via ProteomeXchange with identifier PXD012444. In the verification phase, the panel was verified in a larger set of KOA patients (n = 262). Finally, ITIH1 and ORM2 were qualified by a blind test in the whole MOVES cohort at baseline. The combination of these biomarkers with clinical variables predict the patients’ response to CS+GH with a specificity of 79.5% and a sensitivity of 77.1%. Conclusions: Combining clinical and analytical parameters, we identified one biomarker that could accurately predict KOA patients’ response to CS+GH treatment. Its use would allow an increase in response rates and safety for the patients suffering KOA.Insituto de Salud Carlos III; PI14/01707Instituto de Salud Carlos III; PI16/02124Insituto de Salud Carlos III; PI17/00404Instituto de Salud Carlos III; DTS17/00200Instituto de Salud Carlos III; CIBER-CB06/01/0040Insituto de Salud Carlos III; RETIC-RIER-RD16/0012/000